XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheet Details
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details Balance Sheet Details
Allowance for Doubtful Accounts
(In thousands)Balance at Beginning of PeriodProvisionsWrite-offs, NetBalance at End of Period
Three months ended March 31, 2023$995 $2 $— $997 
Three months ended March 31, 2022$945 $20 $— $965 

Inventories
(In thousands)March 31, 2023December 31, 2022
Raw materials$41,211 $43,043 
Work-in-process14,749 8,028 
Finished goods53,061 60,809 
Inventories$109,021 $111,880 

Prepaid Expenses and Other Current Assets
(In thousands)March 31, 2023December 31, 2022
Prepayments, advances and deposits$17,233 $18,849 
Non-inventory production supplies8,588 8,138 
Note receivable(1)
4,183 6,871 
Recoverable taxes from Brazilian government entities3,079 870 
Other5,012 5,418 
Total prepaid expenses and other current assets$38,095 $40,146 
                
_______________________
(1) In March 2022, the Company loaned a privately-held company $10 million in exchange for a senior secured convertible promissory note which unless earlier redeemed or converted into equity of the privately-held company, shall be repaid in tranches according to the terms of the Note by June 2023. The Note bears interest at 10% per annum and is convertible, at the Company's option, into equity of the privately-held company upon maturity of the Note or in the event of an initial public offering, equity financing, or corporate transaction (such as a sale or merger), in each case, at a conversion price that is dependent on a variety of factors. In addition, the Note is redeemable prior to maturity, at the issuer's option, in the event of one or more equity or debt financings, one or more asset sales, or an initial public offering, in each case equal to or greater than $65 million. The arrangement is accounted for as a loan. The Company will periodically evaluate the collectability of the loan, and an allowance for credit losses will be recorded if the Company concludes that all or a portion of the loan balance is no longer collectible.

Property, Plant and Equipment, Net
(In thousands)March 31, 2023December 31, 2022
Machinery and equipment$151,964 $149,413 
Leasehold improvements51,744 51,426 
Building29,389 29,389 
Computers and software10,441 10,356 
Furniture and office equipment, vehicles and land4,111 3,979 
Construction in progress50,310 41,012 
297,959 285,575 
Less: accumulated depreciation and amortization(108,314)(103,351)
Property, plant and equipment, net$189,645 $182,224 

During the three months ended March 31, 2023 and 2022, depreciation and amortization expense, including amortization of right-of-use assets under financing leases, but without amortization of intangible assets, was as follows:
Three Months Ended March 31,
(In thousands)20232022
Depreciation and amortization expense, without amortization of intangible assets$4,527 $2,400 

Goodwill
(In thousands)March 31, 2023December 31, 2022
Beginning balance$142,575 $131,259 
Acquisitions— 22,231 
Impairment(94,351)— 
Effect of currency translation adjustment2,232 (10,915)
Ending balance$50,456 $142,575 

The Company performed an interim impairment analysis using financial information through March 31, 2023 as well as forecasts for cash flows developed using the Company's three-year strategic plan. The Company’s annual impairment test is performed on October 1. All of the Company's goodwill resides within the Consumer reporting unit. The interim impairment analysis was performed due to the identification of a triggering event resulting from the Company's decision during the three months ended March 31, 2023 to exit the EcoFabulous brand and reorganize the Beauty Labs business. Due to the isolated nature of the identified triggering event, the interim impairment review was limited to the Beauty Labs business and the EcoFabulous brand. The analysis indicated that the carrying amount of the goodwill for the Consumer reporting unit was greater than its fair value. The impairment was calculated as the difference between the fair value, determined in the interim impairment review, and the carrying value. The results of the impairment analysis indicated that $94.4 million of goodwill related to the Beauty Labs business and the EcoFabulous brand was impaired as of March 31, 2023. The Company will continue to evaluate the fair value of goodwill and intangible assets through the fourth quarter of fiscal 2023 for potential impairment.

Intangible Assets, Net

During the twelve months ended December 31, 2022, the Company acquired $14.6 million of intangible assets related to trademarks and trade names, customer relationships, developed technology, and patents as a result of the acquisitions completed during the year.

March 31, 2023December 31, 2022
(In thousands)Estimated Useful Life
(in Years)		GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Trademarks and trade names, and branded products10$20,023 $2,442 $17,581 $21,042 $1,948 $19,094 
Customer relationships
5 - 16
8,233 1,327 6,906 8,182 1,045 7,137 
Developed technology and software applications
5 - 12
21,872 1,837 20,035 21,472 1,315 20,157 
Patents17600 59 541 600 50 550 
Total intangible assets$50,728 $5,665 $45,063 $51,296 $4,358 $46,938 

The Intangible assets, net balance as of March 31, 2023 includes impairment charges of $1.0 million related to the Beauty Labs trademark. Amortization expense for intangible assets was $1.3 million and $0.9 million for the three months ended March 31, 2023 and 2022, and is included in general and administrative expenses.

Total future amortization of intangible assets as of March 31, 2023 is as follows (in thousands):

(In thousands)
2023 (remainder)$3,939 
20246,323 
20256,433 
20266,161 
20275,262 
Thereafter16,945 
Total future amortization$45,063 

Leases

Operating Leases

The Company has operating leases primarily for administrative offices, laboratory equipment and other facilities. The operating leases have remaining terms that range from 1 to 17 years, and often include one or more options to renew. These renewal terms can extend the lease term for an additional 1 to 5 years and are included in the lease term when it is reasonably certain that the Company will exercise the option. The operating leases are classified as right-of-use (ROU) assets under operating leases on the Company's condensed consolidated balance sheets and represent the Company’s right to use the underlying asset for the lease term. The Company’s obligation to make operating lease payments is included in "Lease liabilities" and "Lease liabilities, net of current portion" on the Company's condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company had $100.7 million and $97.2 million of operating lease ROU assets as of March 31, 2023 and December 31, 2022. Operating lease liabilities were $93.5 million and $88.5 million as of March 31, 2023 and December 31, 2022. During the three months ended March 31, 2023 and 2022, the Company recorded $6.9 million and $3.7 million, respectively, of operating lease amortization that was charged to expense, of which $0.6 million and $0.3 million, respectively, was recorded to cost of products sold.

Because the rate implicit in each lease is not readily determinable, the Company uses its incremental borrowing rate to determine the present value of the lease payments. The Company has certain contracts for real estate and marketing which may contain lease and non-lease components, which it has elected to treat as a single lease component.

Information related to the Company's ROU assets and related lease liabilities were as follows:

Three Months Ended March 31,
20232022
Cash paid for operating lease liabilities, in thousands$4,620$3,045
Right-of-use assets obtained in exchange for new operating lease obligations, in thousands$—$18,759
Weighted-average remaining lease term (in years)11.28.7
Weighted-average discount rate22.6%19.0%

Financing Leases

The Company has financing leases primarily for laboratory equipment. Assets purchased under financing leases are included in "Right-of-use assets under financing leases, net" on the condensed consolidated balance sheets. For financing leases, the associated assets are depreciated or amortized over the shorter of the relevant useful life of each asset or the lease term. Accumulated amortization of assets under financing leases totaled $1.6 million and $1.6 million as of March 31, 2023 and December 31, 2022, respectively.

Maturities of Financing and Operating Leases

Maturities of lease liabilities as of March 31, 2023 were as follows:
Years ending December 31:
(In thousands)
Financing
Leases		Operating
Leases		Total Leases
2023 (Remaining Nine Months)$16 $14,989 $15,005 
202421 23,808 23,829 
202521 23,361 23,382 
202616 24,649 24,665 
2027— 25,888 25,888 
Thereafter— 222,233 222,233 
Total lease payments74 334,928 335,002 
Less: amount representing interest(16)(241,458)(241,474)
Total lease liability$58 $93,470 $93,528 
Current lease liability$14 $2,484 $2,498 
Noncurrent lease liability44 90,986 91,030 
Total lease liability$58 $93,470 $93,528 

Other Assets

(In thousands)March 31, 2023December 31, 2022
Investments in equity securities$7,892 $7,892 
Equity-method investments in affiliates3,000 $3,000 
Deposits531 530 
Notes receivable, net of current portion— 671 
Other2,239 1,811 
Total other assets$13,662 $13,904 
Accrued and Other Current Liabilities

(In thousands)March 31, 2023December 31, 2022
Payroll and related expenses$23,308 $18,795 
Accrued interest19,212 14,639 
Liability in connection with acquisition of equity-method investment10,800 11,275 
Deferred consideration payable(1)
6,200 7,883 
Professional services4,216 4,826 
Asset retirement obligation(2)
3,872 3,763 
Contract termination fees1,379 1,369 
License fee payable1,050 1,050 
Tax-related liabilities— 829 
Other11,031 9,136 
Total accrued and other current liabilities$81,068 $73,565 
______________
(1)    Deferred consideration payable is the current portion of total acquisition-related contingent consideration.
(2)    The asset retirement obligation represents liabilities incurred but not yet discharged in connection with the Company's 2013 abandonment of a partially constructed facility in Pradópolis, Brazil.